ClinicalTrials.Veeva

Menu

HPV Genotype Attribution and Disease Burden of Anal Cancer in China

Fudan University logo

Fudan University

Status

Not yet enrolling

Conditions

Anal Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT06670495
2024-225-3778

Details and patient eligibility

About

To demonstrate HPV prevalence and its genotype distributions in anal cancer in China and to describe demographic and clinical features of HPV-related anal cancer in China; To describe the epidemiological characteristics ,trends and of disease burden of anal cancer in China

Enrollment

300 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • (1) Patients diagnosed with anal cancers, (2) Patients without radiation or chemotherapy prior to specimen collection;

Exclusion criteria

  • (1) Patients with HIV infection, (2) Patients with immunosuppression after solid organ transplantation, (3) Those who do not agree to specimen collection and testing, (4) For retrospective study cases, those who without specimen.

Trial contacts and locations

0

Loading...

Central trial contact

Ying Zheng

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems